Equities analysts predict that Addus Homecare Co. (NASDAQ:ADUS) will post $141.40 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Addus Homecare’s earnings. The lowest sales estimate is $138.46 million and the highest is $143.66 million. Addus Homecare reported sales of $111.96 million during the same quarter last year, which indicates a positive year-over-year growth rate of 26.3%. The business is scheduled to issue its next earnings results on Monday, March 4th.
On average, analysts expect that Addus Homecare will report full year sales of $520.59 million for the current financial year, with estimates ranging from $516.78 million to $523.80 million. For the next fiscal year, analysts anticipate that the firm will report sales of $603.66 million, with estimates ranging from $572.95 million to $652.00 million. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that cover Addus Homecare.
Addus Homecare (NASDAQ:ADUS) last released its quarterly earnings results on Tuesday, November 6th. The company reported $0.48 EPS for the quarter, topping the Zacks’ consensus estimate of $0.40 by $0.08. The company had revenue of $137.63 million for the quarter, compared to analyst estimates of $139.43 million. Addus Homecare had a return on equity of 10.70% and a net margin of 3.25%.
A number of equities research analysts recently issued reports on the company. BidaskClub raised Addus Homecare from a “buy” rating to a “strong-buy” rating in a research report on Friday, July 20th. Cantor Fitzgerald assumed coverage on Addus Homecare in a research report on Wednesday, September 12th. They issued an “overweight” rating and a $77.00 target price on the stock. Royal Bank of Canada assumed coverage on Addus Homecare in a research report on Monday, October 8th. They issued an “outperform” rating and a $81.00 target price on the stock. Zacks Investment Research lowered Addus Homecare from a “hold” rating to a “strong sell” rating in a research report on Monday, October 22nd. Finally, Raymond James assumed coverage on Addus Homecare in a research report on Monday, August 20th. They issued an “outperform” rating and a $75.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. Addus Homecare has a consensus rating of “Buy” and a consensus target price of $73.50.
Shares of Addus Homecare stock opened at $72.49 on Friday. Addus Homecare has a 52-week low of $30.95 and a 52-week high of $76.89. The company has a market capitalization of $889.87 million, a P/E ratio of 49.99, a PEG ratio of 2.82 and a beta of -0.26. The company has a current ratio of 3.09, a quick ratio of 3.09 and a debt-to-equity ratio of 0.53.
In related news, major shareholder Eos Capital Partners Iii L. P sold 1,024,733 shares of Addus Homecare stock in a transaction that occurred on Monday, August 20th. The stock was sold at an average price of $59.00, for a total value of $60,459,247.00. The sale was disclosed in a document filed with the SEC, which is available at this link. 34.80% of the stock is currently owned by company insiders.
A number of hedge funds have recently bought and sold shares of ADUS. Eos Management L.P. grew its stake in Addus Homecare by 4,991.1% in the third quarter. Eos Management L.P. now owns 190,221,406 shares of the company’s stock valued at $2,712,000 after purchasing an additional 186,485,035 shares in the last quarter. BlackRock Inc. grew its stake in Addus Homecare by 24.9% in the third quarter. BlackRock Inc. now owns 731,017 shares of the company’s stock valued at $51,281,000 after purchasing an additional 145,736 shares in the last quarter. Renaissance Technologies LLC grew its stake in Addus Homecare by 191.1% in the second quarter. Renaissance Technologies LLC now owns 183,700 shares of the company’s stock valued at $10,517,000 after purchasing an additional 120,600 shares in the last quarter. Acadian Asset Management LLC bought a new position in Addus Homecare in the second quarter valued at approximately $4,690,000. Finally, ClariVest Asset Management LLC bought a new position in Addus Homecare in the second quarter valued at approximately $3,781,000. Hedge funds and other institutional investors own 82.42% of the company’s stock.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company's personal care services offer assistance with activities of daily living. Its services include assistance with bathing, grooming, oral care, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services, as well as other activities of daily living.
Recommended Story: Trading Strategy Methods and Types
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.